Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response

Abstract

Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response RAD IATION THERAPY (3DCRT) DEBATE SERIESRadiation Oncology is a highly multidisciplinary medical specialty, drawing significantly from three scientific disciplinesmedicine, physics, and biology. As a result, discussion of controversies or changes in practice within radiation oncology involves input from all three disciplines. For this reason, significant effort has been expended recently to foster collaborative multidisciplinary research in radiation oncology, with substantial demonstrated benefit. 1,2 In light of these results, we endeavor here to adopt this "team-science" approach to the traditional debates featured in this journal. This article is part of a series of special debates entitled "Three Discipline Collaborative Radiation Therapy (3DCRT)" in which each debate team will include a radiation oncologist, medical physicist, and radiobiologist. We hope that this format will not only be engaging for the readership but will also foster further collaboration in the science and clinical practice of radiation oncology.

Expanding the reach of medical physics: Immunotherapy should be included as part of the curriculum for medical physics education and training

“…Or perhaps a more relevant question is how impactful is this concept to the field of radiation oncology? One of our previous parallel opposed editorials discussed whether the immunotherapy dictates the future of SBRT . In the current issue, the discussion continues on the importance of this new emergent field to our medical physics profession.…”